inhibrx inc shares fell 15 to 2207 after the company said chief medical officer klaus wagner intends to resign to pursue another opportunity the company said in a filing with the us securities and exchange commission his departure isnt due to any disagreement with the company regarding its operations policies or procedures the company expects to enter into an agreement with dr wagner in connection with his departure to provide for among other matters a stock option exercise extension a release and waiver of claims and continued compliance with his confidentiality obligations